NTRR Moves to Make Plant Health an Investable Proposition

Neutra Corp. (NTRR) announced today that the company has signed a letter of intent with Colorado plant specialists Green Mountain Plant Health, LLC, to supply a line of antimicrobial products for the healthy treatment of industrial cannabis crops and other indoor agricultural projects.

The agreement is a big step forward for NTRR as it works to become a major provider in the fast-growing U.S. cannabis industry. Alongside its joint venture partner Surface to Air Solutions (S2O2), NTRR is marketing a suite of horticultural products carefully engineered to keep plants, surfaces and air inside growing facilities free from mold, microbes, fungus and other adulterants without the use of potentially harmful pesticides. Testing recently commenced on the joint venture’s antimicrobial surface treatment, nutritional plant tonic and air-scrubbing hydroxyl generator at facilities run by two of Colorado’s most respected cannabis organizations.

If a definitive agreement with Green Mountain Plant Health is signed during the company’s 90-day option period, GMPH will begin applying and installing Neutra Corp. and S2O2’s products at clients’ growing facilities across Colorado—the nation’s top cannabis market.

“Plant-health service providers such as Green Mountain are constantly seeking out new and better ways to help their clients achieve optimum growing conditions,” said NTRR CEO Chris Brown. “Our joint venture with S2O2 was formed to help revolutionize plant care in this industry, and forging an alliance with Green Mountain could allow both of our companies to reach the next level in this industry.”

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), INSYS Therapeutics, Inc. (INSY) and ENDEXX Corp. (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com
Posted in: Press

Comments are closed.